Bright Minds Biosciences Inc. (DRUG)

NASDAQ

$61.95

$+1.57

(+2.64%)

Regular Market

Bright Minds Biosciences Inc. (DRUG) Live Price Chart

Last updated: ⁦2026-09-22 15:22:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Bright Minds Biosciences Inc. (DRUG) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $61.95, with a market capitalization of $598.34M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $48.90 to $123.75. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$598.34M
Open	$60.36
Day's High	$123.75
Day's Low	$0.93
Previous Close	$59.46
Volume	17.76K
Average Volume	186.11K
P/E Ratio	--
52-Week High	$123.75
52-Week Low	$48.90
Dividend Yield	--
Earnings Date	--

Bright Minds Biosciences Inc. (DRUG) Stock Price Today

Bright Minds Biosciences Inc. (DRUG) is currently trading at $61.95 as of 2026-09-22 15:21:00, up 4.19% ($2.49) from the previous close of $59.46

During today's regular trading session, DRUG has traded between $0.93 and $123.75, with a trading volume of 17.76K shares. The current price is near the middle of today's range.

Bright Minds Biosciences Inc. (DRUG) 7-Day Stock Price Change

Over the past seven days, Bright Minds Biosciences Inc. (DRUG) moved from $63.18 to $61.95, representing a decline of 1.94% ($1.23).

The stock traded between $57.58 and $66.25 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 89.89 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

DRUG 52-Week Price Position

Position in Range: 17.4%

52W Low$48.90

52W High$123.75

DRUG is currently trading at $61.95, placing it 17.4% of the way from its 52-week low of $48.90 to its 52-week high of $123.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Bright Minds Biosciences Inc. (DRUG)?

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Bright Minds Biosciences Inc. Information

Employees	25
Exchange	NASDAQ
Company Website	https://www.brightmindsbio.com

How to Buy Bright Minds Biosciences Inc. (DRUG) Stock on MEXC

Eligible investors can buy real shares of Bright Minds Biosciences Inc. (DRUG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DRUG and Place Your Order

Open the RealStocks trading page and search for DRUG. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Bright Minds Biosciences Inc. (DRUG) stock price today?

Bright Minds Biosciences Inc. (DRUG) is currently trading at $ 61.95, up 4.19% ($2.49) from the previous close of $ 59.46. Intraday prices update in real time during regular trading hours.

2.Is DRUG stock going up or down today?

As of 2026-09-22 15:21:00, DRUG is trading at $ 61.95, up 4.19% ($2.49) from its previous close of $ 59.46. The stock has traded between $ 0.93 and $ 123.75 during today’s regular session. Past price movements do not guarantee future results.

3.What is DRUG pre-market price?

As of 2026-09-22 15:21:00, DRUG is trading at $ 60.60 in pre-market trading, up 1.92% ($1.14) from the previous close of $ 59.46. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DRUG after-hours price?

As of 2026-09-22 15:21:00, DRUG is trading at $ 61.25 in after-hours trading, up 3.01% ($1.79) from the regular-session close of $ 59.46. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DRUG stock trading now?

DRUG trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DRUG sit relative to its 52-week high and low?

Over the past 52 weeks, DRUG has traded between a low of $ 48.90 and a high of $ 123.75. At $ 61.95, the stock is positioned 17.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Bright Minds Biosciences Inc. in?

Bright Minds Biosciences Inc. (DRUG) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Bright Minds Biosciences Inc.'s market capitalization and where is it listed?

Bright Minds Biosciences Inc. is listed on the NASDAQ exchange with a market capitalization of $ 598.34M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DRUG valued in terms of P/E ratio and EPS?

DRUG trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Bright Minds Biosciences Inc. pay a dividend?

Bright Minds Biosciences Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.